CNTACENTESSA PHARMACEUTICALS LTD
CUSIP 152309100 · depositary receipt
No tracked investor reported shares of CENTESSA PHARMACEUTICALS LTD (CNTA) for Q2 2026. 5 investors sold out this quarter, including Perceptive Advisors.
Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding CNTA · Q2 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 4.08% | 5,258,903 | $208.9M | EXIT |
| Lee Ainslie | 0.85% | 1,854,488 | $73.7M | EXIT |
| Julian Baker | 0.15% | 670,751 | $26.6M | EXIT |
| Chuck Royce | 0.11% | 278,064 | $11M | EXIT |
| Adar1 Capital Management | 0.09% | 38,566 | $1.5M | EXIT |